Edgewise Therapeutics, Inc. Common Stock
EWTX
EWTX: Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.
moreShow EWTX Financials
Recent trades of EWTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by EWTX's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Pyridazinone compounds and uses thereof Jul. 19, 2022
-
Patent Title: Pyridazinone compounds and uses thereof Feb. 01, 2022
-
Patent Title: Pyridazinone compounds and uses thereof Aug. 17, 2021
Federal grants, loans, and purchases
Followers on EWTX's company Twitter account
Number of mentions of EWTX in WallStreetBets Daily Discussion
Recent insights relating to EWTX
Recent picks made for EWTX stock on CNBC
ETFs with the largest estimated holdings in EWTX
Flights by private jets registered to EWTX